Cencora, Inc.
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cencora, Inc. and other ETFs, options, and stocks.About COR
Cencora, Inc. is a pharmaceutical sourcing and distribution services company. It operates through the United States (U.S.) Healthcare Solutions and International Healthcare Solutions segments.
COR Key Statistics
Stock Snapshot
With a market cap of 69.69B, Cencora, Inc.(COR) trades at $358.26. The stock has a price-to-earnings ratio of 43.12 and currently yields dividends of 70.4%.
On 2026-03-09, Cencora, Inc.(COR) stock traded between a low of $354.90 and a high of $360.10. Shares are currently priced at $358.26, which is +0.9% above the low and -0.5% below the high.
The Cencora, Inc.(COR)'s current trading volume is 245.85K, compared to an average daily volume of 1.08M.
In the last year, Cencora, Inc.(COR) shares hit a 52-week high of $377.54 and a 52-week low of $251.94.
In the last year, Cencora, Inc.(COR) shares hit a 52-week high of $377.54 and a 52-week low of $251.94.
COR News
Advertisement Event context and recent share performance Cencora (COR) has drawn investor attention after recent trading saw the stock slip around 0.2% in the...
Cencora (NYSE:COR) held its annual shareholder meeting, confirming all board nominees. Shareholders approved the company's executive compensation plans. A new...
Cencora ( (COR) ) has shared an announcement. Cencora held its 2026 Annual Meeting of Shareholders on March 5, 2026, at which investors elected eleven director...
Analyst ratings
76%
of 17 ratingsMore COR News
BofA analyst Allen Lutz raised the firm’s price target on Cencora (COR) to $380 from $360 and keeps a Neutral rating on the shares. McKesson (MCK) “quietly” rec...
Gallant, an animal health biotechnology company, recently announced a fulfillment agreement with MWI Animal Health, part of Cencora, to build the first ultra-lo...